Does ADHD medication stop working after 2-3 years? On the surprising, but littleknown follow-up of the MTA study;Is ADHD-medicatie na 2-3 jaar uitgewerkt? Over de verrassende, maar weinig bekende follow-up van het MTA-onderzoek

Tijdschrift voor Psychiatrie

Volumn 52, Issue 4, 2010, Pages 245-254

  Nieweg, E H ^a  

^a Jonx/Lentis ^*  (Netherlands)

Author keywords

Attention deficit hyperactivity disorder (ADHD); Follow up; Methylphenidate; Multimodal Treatment Study of Children with ADHD (MTA)

Indexed keywords

CENTRAL STIMULANT AGENT; METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; CHILD; CLINICAL STUDY; DETERIORATION; DRUG EFFICACY; FOLLOW UP; HUMAN; INTENSIVE CARE; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT INDICATION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 77951267234     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Boer, F. (2007). Nadat de onderzoekers het veld hebben vertaten. (Redactioneel). Tijdschrift voor Psychiatrie, 49, 525-527.
2. Buitelaar, J.K. (2000). Medicatie en gedragstherapie bij kinderen met ADHD. Maandblad Geesteltjke volksgezondheid, 55, 565-571.
3. Buitelaar, J.K. (2004). Wat is een voldoende-goede behandeling voor ADHD? Tijdschrift voor Psychiatrie, 46, 27-29.
4. Buitelaar, J.K. (2007). Aandachtstekort-/hyperactiviteitsstoornissen. In F. Verheij, F.C. Verhulst & R.F. Ferdinand (Red.), Kinder- en jeugdpsychiatrie. Behandeling en begeleiding (pp. 99-123). Assen: Van Gorcum.
5. Buitelaar, N. (2009). ADHD en delictgedrag. Tijdschrijt voor Psychiatrie, 51 (Suppl. 1), S32-S33.
6. Buitelaar, N., Ferdinand, R., & Eisenberg, M. (2008). Wat te doen met ADHD-ers die massaal met hun medicatie stoppen. De Waag News Flash, augustus 2008. www.dewaag-utrecht.nl/scripts/download.asp?ID=299.
7. Danckaerts, M. (2006). Aandachtstekortstoornis met hyperactiviteit. In Th. Doreleijers, F. Boer, J. Huisman e.a. (Red.), Leerboek psychiatrie. Kinderen en adolescenten. (pp. 277-286). Utrecht: De Tijdstroom.
8. Gathje, R., Lewandowski, L.J., & Gordon, M. (2008). The role of impairment in the diagnosis of ADHD. Journal of Attention Disorders, 11, 529-537.
9. Gordon, M., Antshel, K., Faraone, S., e.a. (2006). Symptoms versus impairment: the case for respecting DSM-IVs criterion D. Journal of Attention Disorders, 9, 465-475.
10. Jensen, P.S., Arnold, L.E., Swanson, J.M., e.a. (2007). 3-year follow-up of the NIMH MTA study. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 989-1002.
11. Kollins, S.H. (2008). ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines. Journal of Attention Disorders, 12, 115-125.
12. Lewis, S., & Lieberman, J. (2008). CATIE and CUtLASS: can we handle the truth? British journal of Psychiatry, 192, 161-163.
13. Loo-Neus, G.H.H. van de(2006). ADHD. Bijblijven, 22, 25-35.
14. Molina, B.S.G., Flory, K., Hinshaw, S.P., e.a. (2007). Delinquent behaviour and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 1028-1040.
15. Molina, B.S.G., Hinshaw, S.P., Swanson, J.M., e.a. (2009). The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 484-500.
16. MTA Cooperative Group (1999a). A 14-month randomized clinical trial of treatment strategies for Attention-Defidt/Hyperactivity Disorder. Archives of General Psychiatry, 56, 1073-1086.
17. MTA Cooperative Group (1999b). Moderators and mediators of treatment response for children with Attention-Defidt/Hyperactivity Disorder. Archives of General Psychiatry, 56, 1088-1096.
18. MTA Cooperative Group (2004a). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for Attention-Deficit/Hyperactivity Disorder (ADHD). Pediatrics, 113, 754-761.
19. MTA Cooperative Group (2004b). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment Pediatrics, 113, 702-769.
20. Nieweg, E.H. (2008). To be sdentific or not to be? Over psychiatrie en wetenschap. In J.A. den Boer, G. Glas & A.W.M. Mooij (Red.), Kernproblemen van de psychiatrie, (pp. 83-134). Amsterdam: Boom.
21. Nolen, W.A. (2008). Vijftig jaar farmacotherapie van stemmingsstoornissem zijn de verwachtingen uitgekomen? Tijdschrijt voor Psychiatrie, 50 (Suppl. 2), 111-115.
22. Novins, D.K., & De Young, A. (Red.) (2008). The scientific proceedings of the 2008 annual meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, October 28-November 2, 2008. pp.91-93.
23. Pelham, W.E. (1999). The NIMH multimodal treatment study for attention-deficit hyperactivity disorder: just say yes to drugs alone? Canadian journal of Psychiatry, 44, 981-990.
24. Rorry, R. (1980). Philosophy and the mirror of nature. Oxford: Basil Blackwell.
25. Shaw, P., Ecksttand, K., Sharp, W., e.a. (2007). Attention-deficit/ hyperactivity disorder is characterized by a delay in cortical maturation. Proceedings of the National Academy of Sciences, 104, 19649-19654.
26. Swanson, J., Arnold, L.E., Kraemer, H., e.a. (2008a). Evidence, interpretation and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of Children with ADHD (MTA): Part I: Executive summary. Journal of Attention Disorders, 12, 4-14.
27. Swanson, J., Arnold, L.E., Kraemer, H., e.a. (2008b). Evidence, interpretation and qualification from multiple reporrs of long-term outcomes in the Multimodal Treatment Study of Children with ADHD (MTA): Part II: Supporting details. Journal of Attention Disorders, 12, 15-43.
28. Swanson, J., Elliott, G.R., Greenhill, L.L., e.a. (2007a). Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 1015-1027.
29. Swanson, J., Hinshaw, S.P., Arnold, L.E., e.a. (2007b). Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 1003-1014.
30. Swanson, J., & Volkow, N.D. (2009). Psychopharmacology: concepts and opinions about the use of stimulant medications. Journal of Child Psychology and Psychiatry, 50, 180-193.
31. Vanderschuren, L.J.M.J., Matthys, W., & van der Brink, W. (2009). Stoornissen van de impulsregulatie. Pathofysiologie en behandeling. NederlandsTtjdschri/tvoorGeneeskunde, 153, 240-243.
32. Volkow, N.D., & Swanson, J. (2008). Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood? (Editorial.) American journal of Psychiatry, 165, 553-555.
33. Werkgroep Multidisciplinaire Richtlijn ADHD bij Kinderen en Jeugdigen (2005). Multidisciplinaire Richtlijn ADHD (2005). Richtlijn voor de diagnostiek en behandeling van ADHD bij kinderen en jeugdigen. Utrecht: Trimbos-instituut.
34. Wilens, T.E., Biederman, J., Faraone, S.V., e.a. (2003). Does stimulant therapy of ADHD beget later substance abuse? A meta-analytic review of the literature. Pediatrics, 111, 179-185.